Afuco™ Anti-Human Glycosphingolipid ADCC Therapeutic Antibody, ADCC Enhanced
Anti-Glycosphingolipid ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-extended Type I glycosphingolipid antibodies are used in the treatment or prevention of diseases or disorders in mammals, including humans, resulting from improper activity or metabolism of same; resulting, causing or associated with; or the presence thereof, for example, in a cancer, such as colorectal cancer, or other pathology.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-305CL |
| Pricing | Inquiry |
| Host | Human |
| Target | Glycosphingolipid |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided. |